At the time of disease progression to chemotherapy, a recheck of EGFR mutation status over right pleural effusion still yielded T790M mutation, despite a long EGFR-TKI-free period (409 days) and an experience of objective response to chemotherapy. The gene discussed is EGFR; the disease is Pleural effusion.